P058. Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience

被引：0
|
作者：
Filippo Baldacci
Martina Cafalli
Cinzia Lucchesi
Sonia Mazzucchi
Elisa Dini
Ubaldo Bonuccelli
Sara Gori
机构：
[1] University of Pisa,Neurology Unit, Department of Clinical and Experimental Medicine
来源：
The Journal of Headache and Pain | 2015年 / 16卷
关键词：
Migraine; Anxiety Disorder; Generalize Anxiety Disorder; Chronic Migraine; Patient Health Questionnaire;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
    Santos-Lasaosa, S.
    Cuadrado, M. L.
    Gago-Veiga, A. B.
    Guerrero-Peral, A. L.
    Irimia, P.
    Lainez, J. M.
    Leira, R.
    Pascual, J.
    Porta-Etessam, J.
    Sanchez del Rio, M.
    Viguera Romero, J.
    Pozo-Rosich, P.
    NEUROLOGIA, 2020, 35 (08): : 568 - 578
  • [42] 10 Year follow up on 337 patients receiving OnabotulinumtoxinA (Botox) for Chronic Migraine, data from the Hull (UK) Migraine Clinic
    Khan, Rafiullah
    Delrosario, Helen
    Khalil, Modar
    Dorsey, Sophie
    Ijaz, Aamir
    Ahmed, Fayyaz
    CEPHALALGIA, 2023, 43 (1supp)
  • [43] LONG TERM OUTCOME FOR ONABOTULINUMTOXINA THERAPY IN CHRONIC MIGRAINE; A TWO YEAR FOLLOW UP OF 508 PATIENTS FROM THE HULL MIGRAINE CLINIC
    Ahmed, F.
    Khalil, M.
    Tanvir, T.
    Buture, A.
    CEPHALALGIA, 2018, 38 : 86 - 86
  • [44] Long-term experience with onabotulinumtoxina in the treatment of chronic migraine: lessons after one year
    Pascual, J.
    Ramon, C.
    Larrosa, D.
    Riesco, N.
    Alvarez, R.
    Cernuda-Morollon, E.
    CEPHALALGIA, 2015, 35 : 54 - 54
  • [45] Treatment responses to erenumab in onabotulinumtoxinA-refractory chronic migraine: Long-term real-world experience from a specialist headache centre
    Cheng, Fan
    Tang, Ker
    Wan, Shunwei
    Hu, Weihai
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 227 - 227
  • [46] P010. OnabotulinumtoxinA for treatment of chronic migraine: results after 1 year of treatment
    Eleonora Rossi
    Chiara Lupi
    Silvia Benemei
    Pierangelo Geppetti
    Francesco De Cesaris
    The Journal of Headache and Pain, 2015, 16
  • [47] Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine
    Simmonds, Lucy
    Jamtoy, Kent Are
    Aschehoug, Irina
    Hara, Sozaburo
    Meisingset, Tore W.
    Matharu, Manjit S.
    Tronvik, Erling
    Bratbak, Daniel Fossum
    CEPHALALGIA, 2024, 44 (08)
  • [48] Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
    Cernuda-Morollon, Eva
    Ramon, Cesar
    Larrosa, Davinia
    Alvarez, Rocio
    Riesco, Nuria
    Pascual, Julio
    CEPHALALGIA, 2015, 35 (10) : 864 - 868
  • [49] Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UK
    Cheng, F.
    Hussain, M.
    Wilkinson, V.
    Khalil, M.
    Ahmed, F.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
  • [50] Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UK
    Cheng, F.
    Hussain, M.
    Wilkinson, V.
    Khalil, M.
    Ahmed, F.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 262 - 262
12345